Prior corticosteroid treatment alters cPBMC composition and IFNγ response to immunotherapy in canine cancer
BackgroundImmunotherapy using immune checkpoint inhibitors (ICIs) represents a promising therapeutic approach for canine cancer patients. Similar to human cancer patients, the concurrent use of corticosteroids may attenuate the efficacy of immune check…